お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書は、治療用蛋白質の世界市場、容量、生産量、収益、価格の概要を紹介します。2019~2023年の歴史的な市場収益/売上データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。本レポートはメーカー、地域、製品の種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、製品タイプとアプリケーション/端末業界別に治療用蛋白質市場を分類しています。
本レポートでは世界の治療用蛋白質市場の主な参加者として、企業概要、販売数量、収益、価格、粗利益率、ポートフォリオ、地理的位置、重要な発展を次のパラメータに基づいて紹介します。本研究に含まれる主な企業は：Amgen、Abbott Laboratories、AstraZeneca、Baxter International、Boehringer Ingelheim、Chugai Pharmaceutical、Diasome Pharmaceuticals、Eli Lilly、GeneScience Pharmaceuticals、Generex Biotechnology、Genentech

レポートは治療用蛋白質の主要生産者を調査し、主要地域や国の消費状況も提供します。治療用蛋白質の今後の市場の可能性のハイライト、およびこの市場をさまざまなセグメントおよびサブセグメントに予測するための主要な地域/国の焦点。アメリカとカナダ、中国、アジア、ヨーロッパ、中東、アフリカ、ラテンアメリカ、およびその他の国の国別データと市場価値分析。

2019年から2030年までのタイプ別および用途別、売上高、収益、価格別のセグメントデータを分析します。
タイプ別市場セグメント：
    Monoclonal Antibodies
    Erythropoietin
    Insulin
    Interferon
    Human Growth Hormone
    Follicle Stimulating Hormone
    Blood Clotting Factors

用途別の市場セグメント：
    Pharmaceutical Companies
    Healthcare Service Providers
    Research Organizations
    Academic Research Institutes

本レポートの詳細内容
本レポートは、世界の治療用蛋白質市場の現状と将来展望を包括的に分析し、グローバルの主要地域における開発動向の綿密な調査を通じて、読者に包括的な市場分析を提示するものであります。市場の全体像を把握するために、プレイヤー、地域、製品タイプ、最終産業を網羅した多角的な分析を提供しています。さらに、世界市場のトッププレイヤーを特定し、プロファイルを作成するとともに、製品タイプや用途/最終産業に基づいて治療用蛋白質市場を細分化しています。この分類と応用により、市場の構造とダイナミクスをより深く理解することができ、情報に基づいた意思決定と戦略立案が可能になります。
一. 生産面では、2019年から2024年まで、そして2030年までの予測として、メーカー別、地域別（地域レベル、国レベル）の治療用蛋白質生産量、成長率、市場シェアを調査している。

二. 消費面では、治療用蛋白質の売上高を地域別（地域レベル・国レベル）、企業別、種類別、用途別に焦点を当てています。2019年から2024年まで、2030年までの予測。

三.主要メーカーの治療用蛋白質売上高、収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界の治療用蛋白質市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。

四.本治療用蛋白質のレポートでは関係者が市場の競争状況を包括的に理解し、事業戦略や市場戦略を的確に立てるのに役立つ洞察を提供することを目的としています。 売上高、成長動向、生産技術、用途、エンドユーザー産業の市場規模に関する詳細な評価と予測を提供し、意思決定者に強力なデータサポートを提供します。

章の概要
第1章：治療用蛋白質のレポート範囲、各市場セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメントのエグゼクティブサマリー（タイプ別およびアプリケーション別など）を紹介します。市場の現状と、短期から中期、および長期的な進化の可能性を高度に見ることができます。（2019～2030）
第2章： 治療用蛋白質の世界と主要生産者（地域／国）の生産／アウトプット。各生産者の生産量と今後6年間の発展可能性を定量的に分析しています。（2019～2030）
第3章：世界、地域、国レベルにおける治療用蛋白質の売上（消費）、収益。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界の各国の市場発展、将来の発展の見通し、市場空間を紹介します。（2019～2030）
第4章治療用蛋白質メーカーの競争状況、価格、売上高、収益、市場シェアと業界ランキング、最新の開発計画、合併、買収情報などの詳細分析。（2019～2024）
第5章：治療用蛋白質の各市場セグメントの売上高、収益、平均価格、および開発可能性をカバーした種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第7章：北米（米国・カナダ）：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第8章：ヨーロッパ：タイプ別、用途別、国別、セグメント別の売上高と収益。（2019～2030）
第9章：中国：タイプ別、アプリケーション別、セグメント別の売上高、収益。（2019～2030）
第10章：アジア（中国を除く）：タイプ別、用途別、地域別、セグメント別の売上高、収益。（2019～2030）
第11章：中東、アフリカ、中南米：タイプ別、用途別、国別、セグメント別の売上高、収益。（2019～2030）
第12章：治療用蛋白質の主要メーカーの概要を提供し、製品の説明と仕様、治療用蛋白質の売上高、収益、価格、粗利益率、最近の発展など、市場の主要企業の基本的な状況を詳細に紹介します。（2019～2024）
第13章：産業チェーン、販売チャネル、主要原材料、販売代理店および顧客の分析。
第14章：治療用蛋白質の市場動態、市場の最新の動向、市場の推進要因と制約要因、業界内のメーカーが直面する課題とリスク、業界内の関連政策の分析を紹介します。
第15章：レポートの要点と結論。

Therapeutic proteins are the engineered proteins in the laboratory intended for pharmaceutical use.

The global Therapeutic Protein market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Covers:
This report presents an overview of global market for Therapeutic Protein, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Therapeutic Protein, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Therapeutic Protein, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Therapeutic Protein sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Therapeutic Protein market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Therapeutic Protein sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Amgen, Abbott Laboratories, AstraZeneca, Baxter International, Boehringer Ingelheim, Chugai Pharmaceutical, Diasome Pharmaceuticals, Eli Lilly and GeneScience Pharmaceuticals, etc.

Market Segmentation
By Company
    Amgen
    Abbott Laboratories
    AstraZeneca
    Baxter International
    Boehringer Ingelheim
    Chugai Pharmaceutical
    Diasome Pharmaceuticals
    Eli Lilly
    GeneScience Pharmaceuticals
    Generex Biotechnology
    Genentech

Segment by Type
    Monoclonal Antibodies
    Erythropoietin
    Insulin
    Interferon
    Human Growth Hormone
    Follicle Stimulating Hormone
    Blood Clotting Factors

Segment by Application
    Pharmaceutical Companies
    Healthcare Service Providers
    Research Organizations
    Academic Research Institutes

Segment by Region
    US & Canada
        U.S.
        Canada
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Europe
        Germany
        France
        U.K.
        Italy
        Russia
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Therapeutic Protein in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Therapeutic Protein manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Therapeutic Protein sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.

List of Tables
    Table 1. Global Therapeutic Protein Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Table 2. Major Manufacturers of Monoclonal Antibodies
    Table 3. Major Manufacturers of Erythropoietin
    Table 4. Major Manufacturers of Insulin
    Table 5. Major Manufacturers of Interferon
    Table 6. Major Manufacturers of Human Growth Hormone
    Table 7. Major Manufacturers of Follicle Stimulating Hormone
    Table 8. Major Manufacturers of Blood Clotting Factors
    Table 9. Global Therapeutic Protein Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Table 10. Global Therapeutic Protein Revenue Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 11. Global Therapeutic Protein Revenue by Region (2019-2024) & (US$ Million)
    Table 12. Global Therapeutic Protein Revenue by Region (2025-2030) & (US$ Million)
    Table 13. Global Therapeutic Protein Revenue Market Share by Region (2019-2024)
    Table 14. Global Therapeutic Protein Revenue Market Share by Region (2025-2030)
    Table 15. Global Therapeutic Protein Sales Grow Rate (CAGR) by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 16. Global Therapeutic Protein Sales by Region (2019-2024) & (K MT)
    Table 17. Global Therapeutic Protein Sales by Region (2025-2030) & (K MT)
    Table 18. Global Therapeutic Protein Sales Market Share by Region (2019-2024)
    Table 19. Global Therapeutic Protein Sales Market Share by Region (2025-2030)
    Table 20. Global Therapeutic Protein Sales by Manufacturers (2019-2024) & (K MT)
    Table 21. Global Therapeutic Protein Sales Share by Manufacturers (2019-2024)
    Table 22. Global Therapeutic Protein Revenue by Manufacturers (2019-2024) & (US$ Million)
    Table 23. Global Therapeutic Protein Revenue Share by Manufacturers (2019-2024)
    Table 24. Global Key Players of Therapeutic Protein, Industry Ranking, 2022 VS 2023 VS 2024
    Table 25. Therapeutic Protein Price by Manufacturers 2019-2024 (USD/MT)
    Table 26. Global Therapeutic Protein Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 27. Global Therapeutic Protein by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Protein as of 2023)
    Table 28. Global Key Manufacturers of Therapeutic Protein, Manufacturing Base Distribution and Headquarters
    Table 29. Global Key Manufacturers of Therapeutic Protein, Product Offered and Application
    Table 30. Global Key Manufacturers of Therapeutic Protein, Date of Enter into This Industry
    Table 31. Mergers & Acquisitions, Expansion Plans
    Table 32. Global Therapeutic Protein Sales by Type (2019-2024) & (K MT)
    Table 33. Global Therapeutic Protein Sales by Type (2025-2030) & (K MT)
    Table 34. Global Therapeutic Protein Sales Share by Type (2019-2024)
    Table 35. Global Therapeutic Protein Sales Share by Type (2025-2030)
    Table 36. Global Therapeutic Protein Revenue by Type (2019-2024) & (US$ Million)
    Table 37. Global Therapeutic Protein Revenue by Type (2025-2030) & (US$ Million)
    Table 38. Global Therapeutic Protein Revenue Share by Type (2019-2024)
    Table 39. Global Therapeutic Protein Revenue Share by Type (2025-2030)
    Table 40. Therapeutic Protein Price by Type (2019-2024) & (USD/MT)
    Table 41. Global Therapeutic Protein Price Forecast by Type (2025-2030) & (USD/MT)
    Table 42. Global Therapeutic Protein Sales by Application (2019-2024) & (K MT)
    Table 43. Global Therapeutic Protein Sales by Application (2025-2030) & (K MT)
    Table 44. Global Therapeutic Protein Sales Share by Application (2019-2024)
    Table 45. Global Therapeutic Protein Sales Share by Application (2025-2030)
    Table 46. Global Therapeutic Protein Revenue by Application (2019-2024) & (US$ Million)
    Table 47. Global Therapeutic Protein Revenue by Application (2025-2030) & (US$ Million)
    Table 48. Global Therapeutic Protein Revenue Share by Application (2019-2024)
    Table 49. Global Therapeutic Protein Revenue Share by Application (2025-2030)
    Table 50. Therapeutic Protein Price by Application (2019-2024) & (USD/MT)
    Table 51. Global Therapeutic Protein Price Forecast by Application (2025-2030) & (USD/MT)
    Table 52. US & Canada Therapeutic Protein Sales by Type (2019-2024) & (K MT)
    Table 53. US & Canada Therapeutic Protein Sales by Type (2025-2030) & (K MT)
    Table 54. US & Canada Therapeutic Protein Revenue by Type (2019-2024) & (US$ Million)
    Table 55. US & Canada Therapeutic Protein Revenue by Type (2025-2030) & (US$ Million)
    Table 56. US & Canada Therapeutic Protein Sales by Application (2019-2024) & (K MT)
    Table 57. US & Canada Therapeutic Protein Sales by Application (2025-2030) & (K MT)
    Table 58. US & Canada Therapeutic Protein Revenue by Application (2019-2024) & (US$ Million)
    Table 59. US & Canada Therapeutic Protein Revenue by Application (2025-2030) & (US$ Million)
    Table 60. US & Canada Therapeutic Protein Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 61. US & Canada Therapeutic Protein Revenue by Country (2019-2024) & (US$ Million)
    Table 62. US & Canada Therapeutic Protein Revenue by Country (2025-2030) & (US$ Million)
    Table 63. US & Canada Therapeutic Protein Sales by Country (2019-2024) & (K MT)
    Table 64. US & Canada Therapeutic Protein Sales by Country (2025-2030) & (K MT)
    Table 65. Europe Therapeutic Protein Sales by Type (2019-2024) & (K MT)
    Table 66. Europe Therapeutic Protein Sales by Type (2025-2030) & (K MT)
    Table 67. Europe Therapeutic Protein Revenue by Type (2019-2024) & (US$ Million)
    Table 68. Europe Therapeutic Protein Revenue by Type (2025-2030) & (US$ Million)
    Table 69. Europe Therapeutic Protein Sales by Application (2019-2024) & (K MT)
    Table 70. Europe Therapeutic Protein Sales by Application (2025-2030) & (K MT)
    Table 71. Europe Therapeutic Protein Revenue by Application (2019-2024) & (US$ Million)
    Table 72. Europe Therapeutic Protein Revenue by Application (2025-2030) & (US$ Million)
    Table 73. Europe Therapeutic Protein Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 74. Europe Therapeutic Protein Revenue by Country (2019-2024) & (US$ Million)
    Table 75. Europe Therapeutic Protein Revenue by Country (2025-2030) & (US$ Million)
    Table 76. Europe Therapeutic Protein Sales by Country (2019-2024) & (K MT)
    Table 77. Europe Therapeutic Protein Sales by Country (2025-2030) & (K MT)
    Table 78. China Therapeutic Protein Sales by Type (2019-2024) & (K MT)
    Table 79. China Therapeutic Protein Sales by Type (2025-2030) & (K MT)
    Table 80. China Therapeutic Protein Revenue by Type (2019-2024) & (US$ Million)
    Table 81. China Therapeutic Protein Revenue by Type (2025-2030) & (US$ Million)
    Table 82. China Therapeutic Protein Sales by Application (2019-2024) & (K MT)
    Table 83. China Therapeutic Protein Sales by Application (2025-2030) & (K MT)
    Table 84. China Therapeutic Protein Revenue by Application (2019-2024) & (US$ Million)
    Table 85. China Therapeutic Protein Revenue by Application (2025-2030) & (US$ Million)
    Table 86. Asia Therapeutic Protein Sales by Type (2019-2024) & (K MT)
    Table 87. Asia Therapeutic Protein Sales by Type (2025-2030) & (K MT)
    Table 88. Asia Therapeutic Protein Revenue by Type (2019-2024) & (US$ Million)
    Table 89. Asia Therapeutic Protein Revenue by Type (2025-2030) & (US$ Million)
    Table 90. Asia Therapeutic Protein Sales by Application (2019-2024) & (K MT)
    Table 91. Asia Therapeutic Protein Sales by Application (2025-2030) & (K MT)
    Table 92. Asia Therapeutic Protein Revenue by Application (2019-2024) & (US$ Million)
    Table 93. Asia Therapeutic Protein Revenue by Application (2025-2030) & (US$ Million)
    Table 94. Asia Therapeutic Protein Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 95. Asia Therapeutic Protein Revenue by Region (2019-2024) & (US$ Million)
    Table 96. Asia Therapeutic Protein Revenue by Region (2025-2030) & (US$ Million)
    Table 97. Asia Therapeutic Protein Sales by Region (2019-2024) & (K MT)
    Table 98. Asia Therapeutic Protein Sales by Region (2025-2030) & (K MT)
    Table 99. Middle East, Africa and Latin America Therapeutic Protein Sales by Type (2019-2024) & (K MT)
    Table 100. Middle East, Africa and Latin America Therapeutic Protein Sales by Type (2025-2030) & (K MT)
    Table 101. Middle East, Africa and Latin America Therapeutic Protein Revenue by Type (2019-2024) & (US$ Million)
    Table 102. Middle East, Africa and Latin America Therapeutic Protein Revenue by Type (2025-2030) & (US$ Million)
    Table 103. Middle East, Africa and Latin America Therapeutic Protein Sales by Application (2019-2024) & (K MT)
    Table 104. Middle East, Africa and Latin America Therapeutic Protein Sales by Application (2025-2030) & (K MT)
    Table 105. Middle East, Africa and Latin America Therapeutic Protein Revenue by Application (2019-2024) & (US$ Million)
    Table 106. Middle East, Africa and Latin America Therapeutic Protein Revenue by Application (2025-2030) & (US$ Million)
    Table 107. Middle East, Africa and Latin America Therapeutic Protein Revenue Grow Rate (CAGR) by Country: 2019 VS 2023 VS 2030 (US$ Million)
    Table 108. Middle East, Africa and Latin America Therapeutic Protein Revenue by Country (2019-2024) & (US$ Million)
    Table 109. Middle East, Africa and Latin America Therapeutic Protein Revenue by Country (2025-2030) & (US$ Million)
    Table 110. Middle East, Africa and Latin America Therapeutic Protein Sales by Country (2019-2024) & (K MT)
    Table 111. Middle East, Africa and Latin America Therapeutic Protein Sales by Country (2025-2030) & (K MT)
    Table 112. Amgen Company Information
    Table 113. Amgen Description and Major Businesses
    Table 114. Amgen Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 115. Amgen Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 116. Amgen Recent Developments
    Table 117. Abbott Laboratories Company Information
    Table 118. Abbott Laboratories Description and Major Businesses
    Table 119. Abbott Laboratories Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 120. Abbott Laboratories Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 121. Abbott Laboratories Recent Developments
    Table 122. AstraZeneca Company Information
    Table 123. AstraZeneca Description and Major Businesses
    Table 124. AstraZeneca Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 125. AstraZeneca Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 126. AstraZeneca Recent Developments
    Table 127. Baxter International Company Information
    Table 128. Baxter International Description and Major Businesses
    Table 129. Baxter International Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 130. Baxter International Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 131. Baxter International Recent Developments
    Table 132. Boehringer Ingelheim Company Information
    Table 133. Boehringer Ingelheim Description and Major Businesses
    Table 134. Boehringer Ingelheim Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 135. Boehringer Ingelheim Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 136. Boehringer Ingelheim Recent Developments
    Table 137. Chugai Pharmaceutical Company Information
    Table 138. Chugai Pharmaceutical Description and Major Businesses
    Table 139. Chugai Pharmaceutical Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 140. Chugai Pharmaceutical Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 141. Chugai Pharmaceutical Recent Developments
    Table 142. Diasome Pharmaceuticals Company Information
    Table 143. Diasome Pharmaceuticals Description and Major Businesses
    Table 144. Diasome Pharmaceuticals Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 145. Diasome Pharmaceuticals Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 146. Diasome Pharmaceuticals Recent Developments
    Table 147. Eli Lilly Company Information
    Table 148. Eli Lilly Description and Major Businesses
    Table 149. Eli Lilly Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 150. Eli Lilly Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 151. Eli Lilly Recent Developments
    Table 152. GeneScience Pharmaceuticals Company Information
    Table 153. GeneScience Pharmaceuticals Description and Major Businesses
    Table 154. GeneScience Pharmaceuticals Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 155. GeneScience Pharmaceuticals Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 156. GeneScience Pharmaceuticals Recent Developments
    Table 157. Generex Biotechnology Company Information
    Table 158. Generex Biotechnology Description and Major Businesses
    Table 159. Generex Biotechnology Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 160. Generex Biotechnology Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 161. Generex Biotechnology Recent Developments
    Table 162. Genentech Company Information
    Table 163. Genentech Description and Major Businesses
    Table 164. Genentech Therapeutic Protein Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 165. Genentech Therapeutic Protein Product Model Numbers, Pictures, Descriptions and Specifications
    Table 166. Genentech Recent Developments
    Table 167. Key Raw Materials Lists
    Table 168. Raw Materials Key Suppliers Lists
    Table 169. Therapeutic Protein Distributors List
    Table 170. Therapeutic Protein Customers List
    Table 171. Therapeutic Protein Market Trends
    Table 172. Therapeutic Protein Market Drivers
    Table 173. Therapeutic Protein Market Challenges
    Table 174. Therapeutic Protein Market Restraints
    Table 175. Research Programs/Design for This Report
    Table 176. Key Data Information from Secondary Sources
    Table 177. Key Data Information from Primary Sources
List of Figures
    Figure 1. Therapeutic Protein Product Picture
    Figure 2. Global Therapeutic Protein Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Therapeutic Protein Market Share by Type in 2023 & 2030
    Figure 4. Monoclonal Antibodies Product Picture
    Figure 5. Erythropoietin Product Picture
    Figure 6. Insulin Product Picture
    Figure 7. Interferon Product Picture
    Figure 8. Human Growth Hormone Product Picture
    Figure 9. Follicle Stimulating Hormone Product Picture
    Figure 10. Blood Clotting Factors Product Picture
    Figure 11. Global Therapeutic Protein Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 12. Global Therapeutic Protein Market Share by Application in 2023 & 2030
    Figure 13. Pharmaceutical Companies
    Figure 14. Healthcare Service Providers
    Figure 15. Research Organizations
    Figure 16. Academic Research Institutes
    Figure 17. Therapeutic Protein Report Years Considered
    Figure 18. Global Therapeutic Protein Revenue, (US$ Million), 2019 VS 2023 VS 2030
    Figure 19. Global Therapeutic Protein Revenue 2019-2030 (US$ Million)
    Figure 20. Global Therapeutic Protein Revenue Market Share by Region in Percentage: 2023 Versus 2030
    Figure 21. Global Therapeutic Protein Revenue Market Share by Region (2019-2030)
    Figure 22. Global Therapeutic Protein Sales 2019-2030 ((K MT)
    Figure 23. Global Therapeutic Protein Sales Market Share by Region (2019-2030)
    Figure 24. US & Canada Therapeutic Protein Sales YoY (2019-2030) & (K MT)
    Figure 25. US & Canada Therapeutic Protein Revenue YoY (2019-2030) & (US$ Million)
    Figure 26. Europe Therapeutic Protein Sales YoY (2019-2030) & (K MT)
    Figure 27. Europe Therapeutic Protein Revenue YoY (2019-2030) & (US$ Million)
    Figure 28. China Therapeutic Protein Sales YoY (2019-2030) & (K MT)
    Figure 29. China Therapeutic Protein Revenue YoY (2019-2030) & (US$ Million)
    Figure 30. Asia (excluding China) Therapeutic Protein Sales YoY (2019-2030) & (K MT)
    Figure 31. Asia (excluding China) Therapeutic Protein Revenue YoY (2019-2030) & (US$ Million)
    Figure 32. Middle East, Africa and Latin America Therapeutic Protein Sales YoY (2019-2030) & (K MT)
    Figure 33. Middle East, Africa and Latin America Therapeutic Protein Revenue YoY (2019-2030) & (US$ Million)
    Figure 34. The Therapeutic Protein Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2023
    Figure 35. The Top 5 and 10 Largest Manufacturers of Therapeutic Protein in the World: Market Share by Therapeutic Protein Revenue in 2023
    Figure 36. Global Therapeutic Protein Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 37. Global Therapeutic Protein Sales Market Share by Type (2019-2030)
    Figure 38. Global Therapeutic Protein Revenue Market Share by Type (2019-2030)
    Figure 39. Global Therapeutic Protein Sales Market Share by Application (2019-2030)
    Figure 40. Global Therapeutic Protein Revenue Market Share by Application (2019-2030)
    Figure 41. US & Canada Therapeutic Protein Sales Market Share by Type (2019-2030)
    Figure 42. US & Canada Therapeutic Protein Revenue Market Share by Type (2019-2030)
    Figure 43. US & Canada Therapeutic Protein Sales Market Share by Application (2019-2030)
    Figure 44. US & Canada Therapeutic Protein Revenue Market Share by Application (2019-2030)
    Figure 45. US & Canada Therapeutic Protein Revenue Share by Country (2019-2030)
    Figure 46. US & Canada Therapeutic Protein Sales Share by Country (2019-2030)
    Figure 47. U.S. Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 48. Canada Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 49. Europe Therapeutic Protein Sales Market Share by Type (2019-2030)
    Figure 50. Europe Therapeutic Protein Revenue Market Share by Type (2019-2030)
    Figure 51. Europe Therapeutic Protein Sales Market Share by Application (2019-2030)
    Figure 52. Europe Therapeutic Protein Revenue Market Share by Application (2019-2030)
    Figure 53. Europe Therapeutic Protein Revenue Share by Country (2019-2030)
    Figure 54. Europe Therapeutic Protein Sales Share by Country (2019-2030)
    Figure 55. Germany Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 56. France Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 57. U.K. Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 58. Italy Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 59. Russia Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 60. China Therapeutic Protein Sales Market Share by Type (2019-2030)
    Figure 61. China Therapeutic Protein Revenue Market Share by Type (2019-2030)
    Figure 62. China Therapeutic Protein Sales Market Share by Application (2019-2030)
    Figure 63. China Therapeutic Protein Revenue Market Share by Application (2019-2030)
    Figure 64. Asia Therapeutic Protein Sales Market Share by Type (2019-2030)
    Figure 65. Asia Therapeutic Protein Revenue Market Share by Type (2019-2030)
    Figure 66. Asia Therapeutic Protein Sales Market Share by Application (2019-2030)
    Figure 67. Asia Therapeutic Protein Revenue Market Share by Application (2019-2030)
    Figure 68. Asia Therapeutic Protein Revenue Share by Region (2019-2030)
    Figure 69. Asia Therapeutic Protein Sales Share by Region (2019-2030)
    Figure 70. Japan Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 71. South Korea Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 72. China Taiwan Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 73. Southeast Asia Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 74. India Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 75. Middle East, Africa and Latin America Therapeutic Protein Sales Market Share by Type (2019-2030)
    Figure 76. Middle East, Africa and Latin America Therapeutic Protein Revenue Market Share by Type (2019-2030)
    Figure 77. Middle East, Africa and Latin America Therapeutic Protein Sales Market Share by Application (2019-2030)
    Figure 78. Middle East, Africa and Latin America Therapeutic Protein Revenue Market Share by Application (2019-2030)
    Figure 79. Middle East, Africa and Latin America Therapeutic Protein Revenue Share by Country (2019-2030)
    Figure 80. Middle East, Africa and Latin America Therapeutic Protein Sales Share by Country (2019-2030)
    Figure 81. Brazil Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 82. Mexico Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 83. Turkey Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 84. Israel Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 85. GCC Countries Therapeutic Protein Revenue (2019-2030) & (US$ Million)
    Figure 86. Therapeutic Protein Value Chain
    Figure 87. Therapeutic Protein Production Process
    Figure 88. Channels of Distribution
    Figure 89. Distributors Profiles
    Figure 90. Bottom-up and Top-down Approaches for This Report
    Figure 91. Data Triangulation
    Figure 92. Key Executives Interviewed